Compliance Policy for Combination Product Postmarketing Safety Reporting: Immediately in Effect Guidance for Industry and Food and Drug Administration Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 20, 2019
May 7, 2020
58ccec37-8610-4672-a40f-c7d571feb0f9
Related Documents
Cross-Center Master Files: Where to Submit: Draft Guidance for Industry
Guidance DocumentNovember 25, 2025Office of the Commissioner
Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological Products: Draft Guidance for Industry
Guidance DocumentJune 28, 2024Office of the Commissioner
Submissions for Postapproval Modifications to a Combination Product Approved Under a BLA, NDA, or PMA: Draft Guidance for Industry and FDA Staff
Guidance DocumentJanuary 18, 2013Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.